Nautilus Biotechnology, Inc.
NAUT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $210,717 | $373,508 | $224,260 | $437,524 |
| - Cash | $27,646 | $19,397 | $114,523 | $185,619 |
| + Debt | $30,478 | $34,628 | $30,328 | $30,032 |
| Enterprise Value | $213,549 | $388,739 | $140,065 | $281,937 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$6,353 | -$5,705 | -$3,416 | -$2,842 |
| % Margin | – | – | – | – |
| EBITDA | -$64,427 | -$74,303 | -$54,508 | -$47,473 |
| % Margin | – | – | – | – |
| Net Income | -$70,780 | -$63,675 | -$57,924 | -$50,315 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.56 | -0.51 | -0.46 | -0.6 |
| % Growth | -9.8% | -10.9% | 23.3% | – |
| Operating Cash Flow | -$59,145 | -$51,711 | -$45,806 | -$39,241 |
| Capital Expenditures | -$2,122 | -$2,442 | -$2,324 | -$2,269 |
| Free Cash Flow | -$61,267 | -$54,153 | -$48,130 | -$41,510 |